In fact, these authors have shown that primary ovarian cancer specimens were composed of low densities of cells displaying cancer stem cell markers such as ALDH1A1, CD44 and CD133; tumors collected immediately after primary therapy were more densely composed of each of these markers. This evidence concerns the gene ALDH1A1 and cancer.